Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.

In the ongoing clinical trial of ALA-induced Pp IX photodynamic therapy, the response rate for basal cell carcinomas following a single treatment has been 90% complete response and 7.5% partial response for the first 80 lesions treated.